The ADAP STAR™ assay ready workstation is the instrument of choice for the accurate detection of SARS-CoV-2, only days after infection, using the ultrasensitive quantitative Antibody Detection by Agglutination PCR (ADAP) technology by Enable Biosciences. Critically important prevalence testing within the general population is made possible with throughputs of up to 96 samples at a time.
Specific Kit Supported on this Platform for the SARS-CoV-2 Application
SARS-CoV-2 Rapid Antibody Testing Panel
Antibody Detection by Agglutination PCR (ADAP)
Detection of Type 1 Diabetes Using Antibody Detection by Agglutination-PCR on the ADAP STAR Assay Ready WorkstationAntibody detection assays, such as ELISA, immunoprecipitation, and radioimmunoassays are important tools to diagnose diseases such as Type 1 Diabetes (T1D)1–3. When performed manually, these common yet labor-intensive assays can take up to 22 hours and are subject to inconsistency between technicians and laboratories.
Ultra-Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using the ADAP STAR Assay Ready WorkstationAs of April 16, 2020, there were more than two million confirmed infections of SARS-CoV-2, the virus responsible for Coronavirus Disease 2019 (COVID-19), around the world. In the battle against this rapidly expanding pandemic, successful COVID-19 community screening programs are essential for assessing infection prevalence, aiding identification of infected patients, and enacting appropriate treatment and quarantine protocols.
Hamilton is Customer Service
Whether you need a new instrument or support for one already in the lab, Hamilton is here to support you. Dedicated staff around the world are ready to respond to your request.Contact Us